AACR Virtual Meeting: COVID-19 and Cancer (7.20.20 to 7.22.20)

This block is broken or missing. You may be missing content or you might need to enable the original module.
Anthony Fauci
AACR Covid and Cancer Panel

Join Program Chair and AACR President-Elect David A. Tuveson as he welcomes keynote speakers Anthony Fauci, National Institute of Allergy and Infectious Diseases (NIAID), Solange Peters, CHU Vaudois, and Trevor Bedford, Fred Hutchinson Cancer Research Center, for a special AACR conference focusing on the presentation of emerging data in basic, clinical, and epidemiologic research related to COVID-19 and cancer. 

This timely and exciting program features thought leaders from academia, government agencies, and industry. Emerging data in basic, clinical, and epidemiologic research related to the COVID-19 pandemic and its interactions with cancer will be presented in a mix of keynote lectures, forums, and symposia. 

Time is running out to register for this groundbreaking AACR virtual meeting. COVID-19 has altered our approaches to caring for patients with cancer, and the negative ramifications related to cancer outcomes and methods to mitigate these risks will be discussed. The increased incidence of severe COVID-19 within certain ethnic groups and in association with socioeconomic disparities will also be highlighted as part of this outstanding program.

Under the leadership of AACR President Antoni Ribas and the newly-established AACR COVID-19 and Cancer Task Force, please join Program Chair and AACR President-Elect David A. Tuveson as he welcomes an international array of speakers and panelists from all sectors of the biomedical research community for this special AACR meeting focusing on the presentation of emerging data in basic, clinical, and epidemiologic research related to COVID-19 and cancer.

Highlights of this program include:

Keynote addresses from:

  • Anthony Fauci, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD
  • Solange Peters, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
  • Trevor Bedford, Fred Hutchinson Cancer Research Center, Seattle, WA

A dynamic roster of renowned speakers including:

  • Norman E. Sharpless, Director, National Cancer Institute, Bethesda, MD
  • Kizzmekia S. Corbett, National Institutes of Allergy and Infectious Diseases (NIAID), Bethesda, MD
  • Louis M. Staudt, National Cancer Institute, Bethesda, MD
  • Kevan Shokat, University of California, San Francisco, CA
  • Laura J. Esserman, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
  • Cheryl L. Willman, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
  • John M. Carethers, University of Michigan, Ann Arbor, MI

Twelve interactive symposia covering such topics as:

  • Intersection of the Biology of SARS-CoV-2 and Cancer
  • Effects of Cancer Immunotherapies on Patients with COVID-19 (with and without cancer)
  • COVID-19 Vaccine Development
  • Cancer Drug Repurposing to Treat COVID-19
  • Cancer Prevention and Early Detection During the COVID-19 Pandemic

Six forum discussions featuring timely subjects:

  • Regulatory and Operational Implications of Cancer Clinical Trial Changes During COVID-19
  • Telehealth
  • How Will We bring Patients Back to the Clinic?
  • How Cancer Researchers Are Applying their Talents to COVID-19 Issues
  • Public-Private Partnerships Poised to Address COVID-19
  • Health Disparities

REGISTER

*AACR members register at a reduced rate.

VIEW PROGRAM

This block is broken or missing. You may be missing content or you might need to enable the original module.